Stay updated on T-DXd vs T-DM1 in High-risk HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the T-DXd vs T-DM1 in High-risk HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DXd vs T-DM1 in High-risk HER2+ Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision in the footer changed from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-18T01:52:53.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-03T23:20:55.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    An NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears on the page, and the site revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.5%
    Check dated 2026-10-20T22:53:39.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The website footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-06T23:08:10.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    A new version label, Revision: v3.7.0, was added to the history. Revision: v3.6.6 was removed.
    Difference
    0.1%
    Check dated 2026-09-15T23:52:37.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.6.6, replacing the previous v3.6.5 in the history section, signaling a new build of the Record History page.
    Difference
    0.1%
    Check dated 2026-09-01T20:06:32.000Z thumbnail image

Stay in the know with updates to T-DXd vs T-DM1 in High-risk HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DXd vs T-DM1 in High-risk HER2+ Breast Cancer Clinical Trial page.